The global heparin market was valued at approximately USD 7.56 billion in 2023 and is projected to experience a compound annual growth rate (CAGR) of 2.7% from 2024 to 2030. A significant factor driving this market growth is the rising prevalence of chronic diseases. According to a World Health Organization (WHO) report released in September 2023, noncommunicable diseases (NCDs), often referred...